FDA ALERT
FDA ALERT
11/15/2023

Jessica Ganga

Jessica Ganga
In late September, the FDA approved the first biosimilar to tocilizumab to treat adult and pediatric patients with various indications of arthritis.
11/15/2023
Rheumatologic disorders
Rheumatologic disorders
10/31/2018
Rheumatologic disorders
Rheumatologic disorders
08/28/2017
The US Food and Drug Administration recently approved a biosimilar to Humira for the treatment of multiple inflammatory diseases in adult patients.
08/28/2017